{"AlternateComparison":false,"RelatedProducts":false,"Specification":true,"FeatureBenefit":false}
BD Onclarity™ Molecular biology reagents BD Onclarity™ HPV Assay

Viper LT PCR Accessory Kit

Icon to close the modal
Support
Becton Dickinson Australia & New Zealand
Phone Icon
AU: 1800 656 100
NZ: 0800 572 468
Modal Close Icon
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
For more information, please visit our Contact Us page
Overview

The BD Onclarity™ HPV assay with extended genotyping offers the flexibility you need to adapt to changing screening guidelines and evolving patient management guidance.

In the post-vaccination era the prevalence of high-risk genotypes may change making it crucial to identify high-risk genotypes individually.

  • Extended genotyping supports risk stratification and persistence monitoring to guide patient management1-5
  • Genotypes 16 and 18 account for 70% of invasive cancer worldwide, but their prevalence is declining as vaccination rates increase.6-9
  • Genotypes 31,33,58 have a CIN3+ risk similar to genotype 18, but 51,35,39,68,56,59,66 have a much lower risk.10-11
true
Features and Benefits
Promotional Story
false
Specification

GTIN - Each

00382904429676

1


Quantity - Each

1

GTIN

GTIN - Each 00382904429676 1

Packaging

Quantity - Each 1
Electronic Instructions for Use (eIFUs)
Resources
Frequently Asked Questions
false
Related Products
RELATED PRODUCTS NOT AVAILABLE
References
false
true